Evidence map›Paper›PMID 20061483›Full record

ArticleJournal of bacteriology2010

In Helicobacter pylori, LuxS is a key enzyme in cysteine provision through a reverse transsulfuration pathway.

Neil C Doherty, Feifei Shen, Nigel M Halliday, David A Barrett, Kim R Hardie, Klaus Winzer, John C Atherton

Abstract read
In one paragraph

Article in Journal of bacteriology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. iScience · 2026
    Article
  2. Article
  3. International journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. The Role ofInfection and immunity · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Crystallographic and mutational analyses of cystathionine β-synthase in the HProtein science : a publication of the Protein Society · 2017
    Article
  16. Article
  17. Article
  18. Review
  19. Integration of untargeted metabolomics with transcriptomics reveals active metabolic pathways.Metabolomics : Official journal of the Metabolomic Society · 2014
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Neil C DohertyCentre for Biomolecular Sciences, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom. msxfs@exmail.nottingham.ac.uk
Feifei Shen
Nigel M Halliday
David A Barrett
Kim R Hardie
Klaus Winzer
John C Atherton
University of Nottingham · GBQueen's Medical Centre · GBNottingham University Hospitals NHS Trust · GB

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council G9219778
6 · The paper itself

Abstract

In many bacteria, LuxS functions as a quorum-sensing molecule synthase. However, it also has a second, more central metabolic function in the activated methyl cycle (AMC), which generates the S-adenosylmethionine required by methyltransferases and recycles the product via methionine. Helicobacter pylori lacks an enzyme catalyzing homocysteine-to-methionine conversion, rendering the AMC incomplete and thus making any metabolic role of H. pylori LuxS (LuxS(Hp)) unclear. Interestingly, luxS(Hp) is located next to genes annotated as cysK(Hp) and metB(Hp), involved in other bacteria in cysteine and methionine metabolism. We showed that isogenic strains carrying mutations in luxS(Hp), cysK(Hp), and metB(Hp) could not grow without added cysteine (whereas the wild type could), suggesting roles in cysteine synthesis. Growth of the DeltaluxS(Hp) mutant was restored by homocysteine or cystathionine and growth of the DeltacysK(Hp) mutant by cystathionine only. The DeltametB(Hp) mutant had an absolute requirement for cysteine. Metabolite analyses showed that S-ribosylhomocysteine accumulated in the DeltaluxS(Hp) mutant, homocysteine in the DeltacysK(Hp) mutant, and cystathionine in the DeltametB(Hp) mutant. This suggests that S-ribosylhomocysteine is converted by LuxS(Hp) to homocysteine (as in the classic AMC) and thence by CysK(Hp) to cystathionine and by MetB(Hp) to cysteine. In silico analysis suggested that cysK-metB-luxS were acquired by H. pylori from a Gram-positive source. We conclude that cysK-metB-luxS encode the capacity to generate cysteine from products of the incomplete AMC of H. pylori in a process of reverse transsulfuration. We recommend that the misnamed genes cysK(Hp) and metB(Hp) be renamed mccA (methionine-to-cysteine-conversion gene A) and mccB, respectively.

Indexed as

Metabolic Networks and PathwaysBacterial ProteinsCarbon-Sulfur LyasesComputational BiologyCulture MediaCystathionineCysteineDNA, BacterialGene Knockout TechniquesGene OrderGene Transfer, HorizontalGram-Positive BacteriaHelicobacter pyloriHomocysteineSequence Analysis, DNASulfurBacterial ProteinsCarbon-Sulfur LyasesCulture MediaCystathionineCysteineDNA, BacterialHomocysteineLuxS protein, BacteriaSulfur

Identifiers

PMID20061483
PMCPMC2820867
OpenAlexW2105171421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.